Determination of kynurenic acid in human serum and its correlation with the concentration of certain amino acids

Clinica Chimica Acta

Volumn 377, Issue 1-2, 2007, Pages 174-178

  Fukushima, Takeshi ^a   Mitsuhashi, Shogo ^a   Tomiya, Masayuki ^a   Iyo, Masaomi ^b   Hashimoto, Kenji ^b   Toyo'oka, Toshimasa ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Glutamine; GTK; Human serum; KAT I; Kynurenic acid

Indexed keywords

2 OXOGLUTAMIC ACID; AMINO ACID; GLUTAMIC ACID DERIVATIVE; GLUTAMINE; GLUTAMINE PHENYLPYRUVATE AMINOTRANSFERASE; KYNURENIC ACID; KYNURENINE AMINOTRANSFERASE;

ADULT; AGED; AMINO ACID ANALYSIS; ARTICLE; BIOSYNTHESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; TRANSAMINATION;

ADOLESCENT; ADULT; AGED; AMINO ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; KYNURENIC ACID; MALE; MIDDLE AGED;

EID: 33845501438     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.09.019     Document Type: Article

References (30)

1. Swartz K.J., During M.J., Freese A., and Beal M.F. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J Neurosci 10 (1990) 2965-2973
2. Hilmas C., Pereira E.F.R., Alkondon M., Rassoulpour A., Schwarcz R., and Albuquerque E.X. The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression: physiopathological implications. J Neurosci 21 (2001) 7463-7473
3. Nemeth H., Toldi J., and Vecsei L. Role of kynurenines in the central and peripheral nervous systems. Curr Neurovascular Res 2 (2005) 249-260
4. Hashimoto K., Shimizu E., and Iyo M. Dysfunction of glia-neuron communication in pathophysiology of schizophrenia. Curr Psychiatr Rev 1 (2005) 151-163
5. Hashimoto K., Koike K., Shimizu E., and Iyo M. α7 Nicotinic receptor agonists as potential therapeutic drugs for schizophrenia. Curr Med Chem CNS Agents 5 (2005) 171-184
6. Prescott C., Weeks A.M., Staley K.J., and Partin K.M. Kynurenic acid has a dual action on AMPA receptor responses. Neurosci Lett 402 (2006) 108-112
7. Guidetti P., Okuno E., and Schwarcz R. Characterization of rat brain kynurenine aminotransferases I and II. J Neurosci Res 50 (1997) 457-465
8. Okuno E., Nishikawa T., and Nakamura M. Kynurenine aminotransferases in the rat. Localization and characterization. Adv Exp Med Biol 398 (1996) 455-464
9. Wang J., Simonavicius N., Wu X., et al. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281 (2006) 22021-22028
10. Beal M.F., Matson W.R., Swartz K.J., Gamache P.H., and Bird E.D. Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid. J Neurochem 55 (1990) 1327-1339
11. Connick J.H., Carla V., Moroni F., and Stone T.W. Increase in kynurenic acid in Huntington's disease motor cortex. J Neurochem 52 (1989) 985-987
12. Hzecka J., Kocki T., Stelmasiak Z., and Turski W.A. Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis. Acta Neurol Scand 107 (2003) 412-418
13. Yamamoto H., Murakami H., Horiguchi K., and Egawa B. Studies on cerebrospinal fluid kynurenic acid concentrations in epileptic children. Brain Dev 17 (1995) 327-329
14. Hartai Z., Klivenyi P., Janaky T., Penke B., Dux L., and Vecsei L. Kynurenine metabolism in multiple sclerosis. Acta Neurol Scand 112 (2005) 93-96
15. Schwarcz R., Rassoulpour A., Wu H.Q., Medoff D., Tamminga C.A., and Roberts R.C. Increased cortical kynurenate content in schizophrenia. Biol Psychiatry 50 (2001) 521-530
16. Erhardt S., Schwieler L., and Engberg G. Kynurenic acid and schizophrenia. Adv Exp Med Biol 527 (2003) 155-165
17. Nilsson L.K., Linderholm K.R., Engberg G., et al. Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia. Schizophr Res 80 (2005) 315-322
18. Hzecka J., Stelmasiak Z., Solski J., Wawrzycki S., and Szpetnar M. Plasma amino acids concentration in amyotrophic lateral sclerosis patients. Amino Acids 25 (2003) 69-73
19. van der Heijden F.M.M.A., Fekkes D., Tuinier S., Sijben A.E.S., Kahn R.S., and Verhoeven W.M.A. Amino acids in schizophrenia: evidence for lower tryptophan availability during treatment with atypical antipsychotics?. J Neural Transm 112 (2005) 577-585
20. Mosca M., Cozzi L., Breton J., et al. Molecular cloning of rat kynurenine aminotransferase: identity with glutamine transaminase K. FEBS Lett 353 (1994) 21-24
21. Perry S., Harries H., Scholfield C., et al. Molecular cloning and expression of a cDNA for human kidney cysteine conjugate β-lyase. FEBS lett 360 (1995) 277-280
22. Mosca M., Croci C., Mostardini M., et al. Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs. Biochim Biophys Acta 1628 (2003) 1-10
23. Mitsuhashi S., Fukushima T., Kawai J., et al. Improved method for the determination of kynurenic acid in rat plasma by column-switching HPLC with post-column fluorescence detection. Anal Chim Acta 562 (2006) 36-43
24. Tomiya M., Fukushima T., Kawai J., et al. Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-d-aspartate receptor antagonist, ketamine. Biomed Chromatogr 20 (2006) 628-633
25. Aoyama C., Santa T., Tsunoda M., Fukushima T., Kitada C., and Imai K. A fully automated amino acid analyzer using NBD-F as a fluorescent derivatization reagent. Biomed Chromatogr 18 (2004) 630-636
26. Moroni F., Russi P., Carla V., and Lombardi G. Kynurenic acid is present in the rat brain and its content increases during development and aging processes. Neurosci Lett 94 (1988) 145-150
27. Gramsbergen J.B.P., Schmidt W., Turski W.A., and Schwarcz R. Age-related changes in kynurenic acid production in rat brain. Brain Res 588 (1992) 1-5
28. Cooper A.J.L. The role of glutamine transaminase K (GTK) in sulfur and α-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants. Neurochem Int 44 (2004) 557-577
29. Buchli R., Alberati-Giani D., Malherbe P., Kohler C., Broger C., and Cesura A.M. Cloning and functional expression of a soluble form of kynurenine/alpha-aminoadipate aminotransferase from rat kidney. J Biol Chem 270 (1995) 29330-29335
30. Nilsson LK, Nordin C, Jonsson EG, Engberg G, Linderholm KR, Erhardt S. Cerebrospinal fluid kynurenic acid in male and female controls-Correlation with monoamine metabolites and influences of confounding factors. J Psychiatr Res in press. doi:10.1016/j.jpsychires.2005.12.001.